Medically actionable pathogenic variants in a population of 13,131 healthy elderly individuals-Reference-Cited by-同舟云学术

Medically actionable pathogenic variants in a population of 13,131 healthy elderly individuals

Published:2020-11 Issue:11 Volume:22 Page:1883-1886
ISSN:1098-3600
Container-title:Genetics in Medicine
language:en
Short-container-title:Genetics in Medicine

Author:

Lacaze Paul^ORCID,Sebra Robert,Riaz Moeen,Tiller Jane,Revote Jerico,Phung James,Parker Emily J.,Orchard Suzanne G.,Lockery Jessica E.,Wolfe Rory,Strahl Maya,Wang Ying C.,Chen Rong,Sisco Daniel,Arnold Todd,Thompson Bryony A.,Buchanan Daniel D.,Macrae Finlay A.,James Paul A.,Abhayaratna Walter P.,Lockett Trevor J.,Gibbs Peter,Tonkin Andrew M.,Nelson Mark R.,Reid Christopher M.,Woods Robyn L.,Murray Anne M.,Winship Ingrid,McNeil John J.,Schadt Eric

Publisher

Elsevier BV

Subject

Genetics (clinical)

Link

http://www.nature.com/articles/s41436-020-0881-7.pdf

Reference17 articles.

1. Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics;Kalia;Genet Med,2017

2. The use of ACMG secondary findings recommendations for general population screening: a policy statement of the American College of Medical Genetics and Genomics (ACMG);Directors;Genet Med,2019

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reduced Ejection Fraction in Elite Endurance Athletes: Clinical and Genetic Overlap With Dilated Cardiomyopathy;Circulation;2024-04-30

2. The ASPREE Healthy Ageing Biobank: Methodology and participant characteristics;PLOS ONE;2024-02-29

3. Polygenic risk scores are associated with atrial electrophysiologic substrate abnormalities and outcomes after atrial fibrillation catheter ablation;Heart Rhythm;2023-08

4. Health Characteristics and Aspirin Use in Participants at the Baseline of the ASPirin in Reducing Events in the Elderly – eXTension (ASPREE-XT) Observational Study;Contemporary Clinical Trials;2023-07

5. Incomplete Penetrance and Variable Expressivity: From Clinical Studies to Population Cohorts;Frontiers in Genetics;2022-07-25